1. Home
  2. SCLX vs CDLX Comparison

SCLX vs CDLX Comparison

Compare SCLX & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$0.57

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$1.03

Market Cap

10.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
CDLX
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
10.1M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SCLX
CDLX
Price
$0.57
$1.03
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.43
AVG Volume (30 Days)
★ 73.1K
60.7K
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.13
EPS
N/A
★ N/A
Revenue
$30,253,000.00
★ $233,273,000.00
Revenue This Year
$118.16
N/A
Revenue Next Year
$186.31
$12.53
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.54
$0.55
52 Week High
$23.03
$6.40

Technical Indicators

Market Signals
Indicator
SCLX
CDLX
Relative Strength Index (RSI) 8.42 23.58
Support Level N/A $0.85
Resistance Level $7.77 $1.16
Average True Range (ATR) 0.17 0.17
MACD -0.04 -0.03
Stochastic Oscillator 2.80 9.57

Price Performance

Historical Comparison
SCLX
CDLX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

Share on Social Networks: